{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:36:34Z","timestamp":1793748994826,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG013730"],"award-info":[{"award-number":["AG013730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA219866"],"award-info":[{"award-number":["CA219866"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS087632"],"award-info":[{"award-number":["NS087632"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.expneurol.2020.113252","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T02:29:32Z","timestamp":1582079372000},"page":"113252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons"],"prefix":"10.1016","volume":"329","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0024-0031","authenticated-orcid":false,"given":"Yo","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Engber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert O.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Figley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Bosanac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Devraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Milbrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7262-0968","authenticated-orcid":false,"given":"Aaron","family":"DiAntonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2020.113252_bb0005","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1098014","article-title":"Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration","volume":"305","author":"Araki","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113252_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2202-6-6","article-title":"The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves","volume":"6","author":"Beirowski","year":"2005","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2020.113252_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion","volume":"84","author":"Benatar","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2020.113252_bb0020","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/db18-1233","article-title":"Sarm1 gene deficiency attenuates diabetic peripheral neuropathy in mice","volume":"68","author":"Cheng","year":"2019","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2020.113252_bb0025","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/j.pain.0000000000001528","article-title":"Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy","volume":"160","author":"DiAntonio","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2020.113252_bb0030","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum Neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2020.113252_bb0035","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","article-title":"The SARM1 toll\/interleukin-1 receptor domain possesses intrinsic NAD+cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2020.113252_bb0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cub.2017.12.024","article-title":"TIR domain proteins are an ancient family of NAD+-consuming enzymes","volume":"28","author":"Essuman","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.expneurol.2020.113252_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BST0350109","article-title":"Regulation of calcium signalling by adenine-based second messengers","volume":"35","author":"Fliegert","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2020.113252_bb0050","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/brain\/aww251","article-title":"Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice","volume":"139","author":"Geisler","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2020.113252_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/jci.insight.129920","article-title":"Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program","volume":"4","author":"Geisler","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.expneurol.2020.113252_bb0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1084\/jem.20181040","article-title":"Gene therapy targeting SARM1 blocks pathological axon degeneration in mice","volume":"216","author":"Geisler","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2020.113252_bb0065","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1523\/JNEUROSCI.15-10-06445.1995","article-title":"Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels","volume":"15","author":"George","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113252_bb0070","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1523\/JNEUROSCI.1197-13.2013","article-title":"Sarm1-mediated axon degeneration requires both SAM and TIR interactions","volume":"33","author":"Gerdts","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113252_bb0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD+ destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113252_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000300","article-title":"Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons","volume":"8","author":"Gilley","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2020.113252_bb0085","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bbapap.2014.12.015","article-title":"Calcium mobilizing second messengers derived from NAD","volume":"1854","author":"Guse","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2020.113252_bb0090","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/brain\/aww001","article-title":"Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1","volume":"139","author":"Henninger","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2020.113252_bb0095","doi-asserted-by":"crossref","first-page":"14796","DOI":"10.1074\/jbc.M114.554378","article-title":"Deficiency of nicotinamide mononucleotide adenylyltransferase 3 (nmnat3) causes hemolytic anemia by altering the glycolytic flow in mature erythrocytes","volume":"289","author":"Hikosaka","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113252_bb0100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.aax1911","article-title":"NAD+ cleavage activity by animal and plant TIR domains in cell death pathways","volume":"365","author":"Horsefield","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113252_bb0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2020.113252_bb0110","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1073\/pnas.1809392115","article-title":"Pharmacological bypass of NAD+ salvage pathway protects neurons from chemotherapy-induced degeneration","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2020.113252_bb0115","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1089\/neu.2016.4496","article-title":"Serum Neurofilament light protein as a marker for diffuse axonal injury: results from a case series study","volume":"34","author":"Ljungqvist","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113252_bb0120","doi-asserted-by":"crossref","first-page":"104678","DOI":"10.1016\/j.nbd.2019.104678","article-title":"Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration","volume":"134","author":"Loreto","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2020.113252_bb0125","doi-asserted-by":"crossref","first-page":"113040","DOI":"10.1016\/j.expneurol.2019.113040","article-title":"Sarm1 deletion reduces axon damage, demyelination, and white matter atrophy after experimental traumatic brain injury","volume":"321","author":"Marion","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113252_bb0130","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1523\/JNEUROSCI.5299-06.2007","article-title":"Conditional NF-L transgene expression in mice for in vivo analysis of turnover and transport rate of neurofilaments","volume":"27","author":"Millecamps","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113252_bb0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuron.2017.06.031","article-title":"Axon death pathways converge on axundead to promote functional and structural axon disassembly","volume":"95","author":"Neukomm","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2020.113252_bb0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","article-title":"Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders","volume":"76","author":"Olsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2020.113252_bb0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1223899","article-title":"dSarm\/Sarm1 is required for activation of an injury-induced axon death pathway","volume":"337","author":"Osterloh","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113252_bb0150","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41598-017-18393-9","article-title":"Specific cyclic ADP-ribose phosphohydrolase obtained by mutagenic engineering of Mn2+\u2212dependent ADP-ribose\/CDP-alcohol diphosphatase","volume":"8","author":"Ribeiro","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2020.113252_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2015.03.041","article-title":"Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson\u2019s disease from atypical parkinsonism: evidence from a meta-analysis","volume":"352","author":"Sako","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2020.113252_bb0160","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000004932","article-title":"Plasma neurofilament light chain concentration in the inherited peripheral neuropathies","volume":"90","author":"Sandelius","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2020.113252_bb0165","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1523\/JNEUROSCI.1429-09.2009","article-title":"Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo","volume":"29","author":"Sasaki","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113252_bb0170","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1523\/JNEUROSCI.5469-08.2009","article-title":"Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide","volume":"29","author":"Sasaki","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113252_bb0175","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7554\/eLife.19749","article-title":"NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+depletion","volume":"5","author":"Sasaki","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2020.113252_bb0180","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1523\/JNEUROSCI.0877-14.2014","article-title":"Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons","volume":"34","author":"Summers","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113252_bb0185","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s12035-019-01796-2","article-title":"DLK activation synergizes with mitochondrial dysfunction to downregulate axon survival factors and promote SARM1-dependent axon degeneration","volume":"57","author":"Summers","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2020.113252_bb1000","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1128\/JVI.00836-09","article-title":"The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis","volume":"83","author":"Szretter","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2020.113252_bb0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jns.12219","article-title":"Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy","volume":"22","author":"Turkiew","year":"2017","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2020.113252_bb0195","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1523\/JNEUROSCI.2484-15.2015","article-title":"Live imaging of calcium dynamics during axon degeneration reveals two functionally distinct phases of calcium influx","volume":"35","author":"Vargas","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113252_bb0200","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.aax1771","article-title":"TIR domains of plant immune receptors are NAD+-cleaving enzymes that promote cell death","volume":"365","author":"Wan","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113252_bb0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1083\/jcb.200504028","article-title":"A local mechanism mediates NAD-dependent protection of axon degeneration","volume":"170","author":"Wang","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2020.113252_bb0210","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1212\/WNL.0000000000004667","article-title":"Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration","volume":"89","author":"Weston","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2020.113252_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2014.11.053","article-title":"Pathological axonal death through a MAPK Cascade that triggers a local energy deficit","volume":"160","author":"Yang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2020.113252_bb0220","doi-asserted-by":"crossref","first-page":"22170","DOI":"10.1074\/jbc.M111.228379","article-title":"Cytosolic CD38 protein forms intact disulfides and is active in elevating intracellular cyclic ADP-ribose","volume":"286","author":"Zhao","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113252_bb0225","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.isci.2019.05.001","article-title":"A cell-permeant mimetic of NMN activates SARM1 to produce cyclic ADP-ribose and induce non-apoptotic cell death","volume":"15","author":"Zhao","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.expneurol.2020.113252_bb0230","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jmr.2018.05.005","article-title":"Quantitative imaging of brain energy metabolisms and neuroenergetics using in vivo X-nuclear 2H, 17O and 31P MRS at ultra-high field","volume":"292","author":"Zhu","year":"2018","journal-title":"J. Magn. Reson."},{"key":"10.1016\/j.expneurol.2020.113252_bb0235","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1523\/JNEUROSCI.2343-17.2018","article-title":"Primary traumatic Axonopathy in mice subjected to impact acceleration: a reappraisal of pathology and mechanisms with high-resolution anatomical methods","volume":"38","author":"Ziogas","year":"2018","journal-title":"J. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620300832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620300832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:57:36Z","timestamp":1758002256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488620300832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":48,"alternative-id":["S0014488620300832"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113252","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113252"}}